Previous 10 | Next 10 |
Medpace Holdings Inc. (MEDP) is expected to report $2.04 for Q3 2023
2023-09-28 09:37:00 ET With Intuitive Surgical (NASDAQ: ISRG) vaulting 615% over the last decade, TransMedics Group (NASDAQ: TMDX) , rising 291% in the last three years, and Medpace Holdings (NASDAQ: MEDP) up 324% since 2018, investors may feel like they missed their...
Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2023 financial results after the market close on Monday, October 23, 2023. The Company will host a conference call the following morning, Tuesday, October 24, 2023, at 9:00 a.m. E...
2023-09-09 00:42:46 ET Summary Medpace is a Contract Research Organization (CRO) that provides outsourced clinical development services to the biotech, pharma, and medical device industries. The business model is simpler than it seems and has shown great resilience in complicated ...
2023-08-10 11:50:00 ET Summary Vulcan Value Partners are value investors - business analysts with a long-term time horizon focused on purchasing publicly traded companies that are competitively entrenched at significant discounts to intrinsic worth. All five strategies produced po...
2023-08-07 10:32:15 ET Summary On August 3, 2023, Bruker Corporation, one of the leaders in the scientific instrument market, published its financial report for the second quarter of 2023. Bruker's revenue for the second quarter of 2023 was $681.9 million, down 0.5% from the previ...
2023-07-25 13:54:04 ET Medpace Holdings, Inc. (MEDP) Q2 2023 Earnings Conference Call July 25, 2023, 09:00 AM ET Company Participants Lauren Morris - Director, IR August Troendle - CEO Jesse Geiger - President Kevin Brady - CFO Conference Call Participa...
2023-07-24 16:27:31 ET Medpace press release ( NASDAQ: MEDP ): Q2 GAAP EPS of $1.93 beats by $0.02 . Revenue of $460.8M (+31.2% Y/Y) beats by $27.11M . Revenue of $460.9 million in the second quarter of 2023 increased 31.2% from revenue of $351.2 million for th...
Revenue of $460.9 million in the second quarter of 2023 increased 31.2% from revenue of $351.2 million for the comparable prior-year period, representing a backlog conversion rate of 18.7%. Net new business awards were $574.8 million in the second quarter of 2023, representing an incr...
2023-07-20 09:00:05 ET Summary Medpace Holdings, a Clinical Research Organisation (CRO), has outperformed in the stock market with a return of 429% in the last five years compared to 62% for SPY. CROs, which develop clinical studies for pharma companies, have benefited from increa...
News, Short Squeeze, Breakout and More Instantly...
Medpace Holdings Inc. Company Name:
MEDP Stock Symbol:
NASDAQ Market:
Medpace Holdings Inc. Website:
Revenue of $528.1 million in the second quarter of 2024 increased 14.6% from revenue of $460.9 million for the comparable prior-year period, representing a backlog conversion rate of 18.2%. Net new business awards were $551.0 million in the second quarter of 2024, representing a decrease ...
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...
A look at the top 10 most actives in the United States Qualigen Therapeutics Inc. (QLGN) rose 111.4% to $0.4341 on volume of 412,713,755 shares Maxeon Solar Technologies Ltd. (MAXN) fell 1.3% to $0.2375 on volume of 280,800,277 shares NVIDIA Corporation (NVDA) rose 1.4% to $129.24 on volu...